Sukirti Kalra clinical project manager and Colin Newboul, head of Global Regulatory Affairs & Quality at Wasdell Group examine how clinical trials are adapting with the ongoing Covid-19 pandemic.
Christopher Vakulskas, director of Enzyme Evolution at Integrated DNA Technologies explains how the company’s novel gene editing tools may one day provide single-treatment cures for diseases caused by single gene mutations, including sickle cell dise
EPM speaks to Abdullah Al-Hakimi, senior quality compliance specialist at Autolus and Robert Gaertner, strategy director for Veeva Vault Quality, about working during Covid-19 and why quality processes are so important in pharma.
Hogan Bassey, chief innovation officer and founder of healthcare company LivFul, explains why the industry needs to learn from Covid-19 in order to fight other viruses and diseases.
EPM speaks to Chris Ross, head of Life Science Integrated Supply Chain Operations at Merck to discuss the company's response to Covid-19 and the challenges in developing and supplying vaccines.
EPM speaks to Kevin Deane, vice president of Front-End Innovation and Connected Health at. Phillips-Medisize about the promise of connected health in drug delivery for patients, pharmaceutical providers, and the healthcare industry.
With the popularity for vitamins and other health products continuing to rise, manufacturers must ensure that their products are appropriately packaged in order to minimise risk states Selig’s Peter Tindale, Sales Director.
Jason Lacombe, CEO of software company Veratrak explains why the life sciences industry still needs to improve the way it manages data and the technologies that can help improve supply chains throughout pharma.
Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus.
